240 related articles for article (PubMed ID: 24810004)
1. Quantification of each serogroup polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis.
Gudlavalleti SK; Crawford EN; Harder JD; Reddy JR
Anal Chem; 2014 Jun; 86(11):5383-90. PubMed ID: 24810004
[TBL] [Abstract][Full Text] [Related]
2. Determination of meningococcal serogroups in formulated monovalent and multivalent polysaccharide and polysaccharide-conjugate vaccines.
Cook MC; Kunkel JP
Anal Chem; 2015 May; 87(9):5009-11. PubMed ID: 25837841
[No Abstract] [Full Text] [Related]
3. Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods.
Cook MC; Bliu A; Kunkel JP
Vaccine; 2013 Aug; 31(36):3702-11. PubMed ID: 23764533
[TBL] [Abstract][Full Text] [Related]
4. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
Cohen R; Levy C
Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
[TBL] [Abstract][Full Text] [Related]
6. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
[TBL] [Abstract][Full Text] [Related]
7. Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China.
Cook MC; Gibeault S; Filippenko V; Ye Q; Wang J; Kunkel JP
Biologicals; 2013 Jul; 41(4):261-8. PubMed ID: 23665303
[TBL] [Abstract][Full Text] [Related]
8. Quadrivalent meningococcal conjugate vaccines.
Pace D; Pollard AJ; Messonier NE
Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
[TBL] [Abstract][Full Text] [Related]
9. Simple alternative to sialic acid determination in meningococcal polysaccharides W or Y.
Morduš M; Štimac A; Brgles M; Kurtović T; Halassy B
J Pharm Biomed Anal; 2016 Feb; 120():283-9. PubMed ID: 26760246
[TBL] [Abstract][Full Text] [Related]
10. Quantification of free polysaccharide in meningococcal polysaccharide-diphtheria toxoid conjugate vaccines.
Lei QP; Shannon AG; Heller RK; Lamb DH
Dev Biol (Basel); 2000; 103():259-64. PubMed ID: 11214246
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal group A, C, Y and W-135 conjugate vaccine.
Harrison LH; Mohan N; Kirkpatrick P
Nat Rev Drug Discov; 2010 Jun; 9(6):429-30. PubMed ID: 20514064
[TBL] [Abstract][Full Text] [Related]
12. Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.
Joseph H; Balmer P; Bybel M; Papa T; Ryall R; Borrow R
Clin Diagn Lab Immunol; 2004 Jan; 11(1):1-5. PubMed ID: 14715537
[TBL] [Abstract][Full Text] [Related]
13. Acid hydrolysis conditions for quantification of meningococcal X polysaccharide in a pentavalent vaccine using HPAEC-PAD/ESI-MS.
Ghosh S; Pawar R; Kangralkar V; Mallya AD; Dhere RM; Bolgiano B; Ravenscroft N
Anal Biochem; 2023 Dec; 683():115363. PubMed ID: 37866526
[TBL] [Abstract][Full Text] [Related]
14. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
Pace D
Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
[TBL] [Abstract][Full Text] [Related]
15. Relative stability of meningococcal serogroup A and X polysaccharides.
Berti F; Romano MR; Micoli F; Pinto V; Cappelletti E; Gavini M; Proietti D; Pluschke G; MacLennan CA; Costantino P
Vaccine; 2012 Oct; 30(45):6409-15. PubMed ID: 22921741
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT.
Findlow H; Borrow R
Adv Ther; 2013 May; 30(5):431-58. PubMed ID: 23712402
[TBL] [Abstract][Full Text] [Related]
17. Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.
Deeks ED
Paediatr Drugs; 2012 Feb; 14(1):63-5. PubMed ID: 22149552
[No Abstract] [Full Text] [Related]
18. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.
Wyplosz B; Derradji O; Hong E; François H; Durrbach A; Duclos-Vallée JC; Samuel D; Escaut L; Launay O; Vittecoq D; Taha MK
Transpl Infect Dis; 2015 Apr; 17(2):322-7. PubMed ID: 25645691
[TBL] [Abstract][Full Text] [Related]
19. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
[TBL] [Abstract][Full Text] [Related]
20. Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection.
Ricci S; Bardotti A; D'Ascenzi S; Ravenscroft N
Vaccine; 2001 Feb; 19(15-16):1989-97. PubMed ID: 11228369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
